Compare Acadia Healthcare Company Inc (ACHC) vs Albemarle Corp. (ALB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Acadia Healthcare Company Inc vs Albemarle Corp. — how do they compare? Acadia Healthcare Company Inc trades at $31.3 (market cap $2.90B), while Albemarle Corp. trades at $129.9 (market cap $15.27B). The key difference: Albemarle Corp. is far larger — about 5.3× Acadia Healthcare Company Inc's market cap, and Albemarle Corp. pays a 1.27% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.
| ACHC | ALB | |
|---|---|---|
Market Cap | $2.90B | $15.27B |
Sector | Health | Basic Materials |
52-Week High | $35.61 | $215.62 |
52-Week Low | $11.68 | $72.58 |
Enterprise Value | $5.29B | $17.75B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Albemarle (ALB) trades at $131.21, up 0.08% on the day, showing a bullish technical trend with strong support at $129 and resistance at $133. The company reported robust Q2 2026 results, beating EPS estimates with $3.75 versus $3.20 expected, driven by improved lithium pricing and specialties growth. However, net income remains negative for 2025 at -$510.63M, and the P/E ratio is elevated at 479.11, indicating high valuation expectations. Analyst sentiment is mixed with a consensus price target of $184.50 but only 42% buy ratings.
Outlook: ALB benefits from strong lithium demand and cost controls, but faces risks from volatile lithium prices and sequential margin pressure in Q3. The stock offers growth potential if execution continues, yet high valuation and earnings inconsistency warrant caution. Near-term price action hinges on Q3 results and lithium market trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Acadia Healthcare Company Inc
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →About Albemarle Corp.
Albemarle is the world's largest lithium producer. Our outlook for robust lithium demand is predicated upon increased demand for electric vehicle batteries. Albemarle produces lithium from its salt brine deposits in Chile and the U.S. and its hard rock joint venture mines in Australia. Albemarle is also a global leader in the production of bromine, used in flame retardants. The company is also a major producer of oil refining catalysts.
Read more on ALB →
